Table 2. The risk of having left ventricular hypertrophy (crude odds ratio) for the metabolic syndrome and its different components and insulin as well as physical activity, oestrogen and percentile levels of insulin-like growth factor binding protein-1 and insulin-like growth factor-1.

	Men (n 1822)			Women (n 2049)
	N	Crude OR	95% CI	N	Crude OR	95% CI
MetS	492	1.63	1.17–2.26	416	2.37	1.59–3.54
Waist (>102/88 cm)	495	1.44	1.03-2.01	784	2.21	1.50-3.24
BP (>130/85 mmHg)	1348	3.52	2.11-5.87	1128	4.61	2.77–7.70
TG (>1.7 mmol/l)	476	1.06	0.75–1.51	368	1.55	0.99–2.41
HDL (<1.03/1.3 mmol/l)	330	1.21	0.82–1.79	380	1.00	0.62–1.63
Glucose (≥5.6 mmol/l)	615	1.30	0.95–1.80	381	2.79	1.87–4.15
Insulin (>11.1/10.2 µU/ml)	617	1.37	0.99–1.89	689	2.30	1.57–3.38
PA (high)	611	1.19	0.85–1.66	547	1.04	0.67–1.61
Oestrogen	-	-	-	549	0.47	0.28–0.79
IGFBP-1(10)	221	1.04	0.57–1.90	248	2.56	1.23–5.83
IGFBP-1(20)	180	0.70	0.35–1.38	195	2.43	1.03–5.72
IGFBP-1(30)	168	0.80	0.41–1.58	204	1.49	0.60–3.73
IGFBP-1(40)	165	0.88	0.45–1.71	196	1.42	0.56–3.61
IGFBP-1(50)	193	0.60	0.30–1.21	219	0.67	0.23–1.97
IGFBP-1(60)	209	0.55	0.28–1.11	179	1.12	0.41–3.04
IGFBP-1(70)	154	0.55	0.26–1.18	205	0.97	0.36–2.64
IGFBP-1(80)	201	0.66	0.34–1.30	211	1.44	0.58–3.60
IGFBP-1(90)	160	0.74	0.37–1.49	199	0.77	0.26–2.25
Ref (100)	171	1		193	1
IGF-1(10)	189	0.91	0.45–1.85	201	1.09	0.51–2.33
IGF-1(20)	179	0.53	0.23–1.20	220	0.75	0.32–1.76
IGF-1(30)	197	0.97	0.50–1.90	207	0.30	0.10–0.92
IGF-1(40)	190	1.24	0.64–2.41	210	1.08	0.50–2.36
IGF-1(50)	175	0.91	0.45–1.85	212	0.90	0.40–2.03
IGF-1(60)	173	0.94	0.47–1.87	198	0.75	0.32–1.76
IGF-1(70)	181	1.01	0.50–2.04	193	1.15	0.53–2.49
IGF-1(80)	181	1.06	0.54–2.10	214	0.47	0.18–1.26
IGF-1(90)	179	0.96	0.48–1.91	192	0.97	0.44–2.14
Ref (100)	182	1		202	1

Footnote: MetS, metabolic syndrome; BP, blood pressure; TG, triglycerides; HDL, high-density lipoprotein cholesterol; PA, physical activity; IGFBP-1, insulin-like growth factor binding protein-1; IGF-1, insulin-like growth factor-1.